Lymph Node Disease
16
2
2
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
2 terminated out of 16 trials
75.0%
-11.5% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (16)
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
Is Desmoplastic Stromal Reaction Useful to Modulate Lymph Node Dissection in Sporadic Medullary Thyroid Carcinoma?
D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy
22G-ProCore vs 22G-Standard Needle in Diagnosis of Lymphadenopathy by EBUS-TBNA
The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
LYMPHA: Eliminating the Burden of Lymphedema in Patients Requiring Nodal Dissection
Radiographic Characteristics of Mediastinal and Hilar Lymph Nodes in Sarcoidosis
Identifying Ultrasonic Diagnostic Characteristics of Cervical Lymphadenopathy: A Retrospective, Multicenter Study
Survival of Patients With a Reduction in the Number of Lymph Nodes in Rectal Cancer After Neoadjuvant Chemoradiotherapy
Prediction Model of CP-EBUS in the Diagnosis of Lymph Nodes
Fluorescence Targeted Pelvic Lymph Node Mapping
Role of Color Doppler Ultrasound in Lymphadenopathy
Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIRE®)
Evolution of Indications for Transbronchial Ganglionic Ultrasound
Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis
Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes